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ABSTRACT
Background. Although some studies have suggested that
low preoperative 25-hydroxyvitamin D (25-OHD) levels
may increase the risk of hypocalcemia and decrease the
accuracy of single quick parathyroid hormone in predicting
hypocalcemia after total thyroidectomy, the literature
remains scarce and inconsistent. Our study aimed to
address these issues.
Methods. Of the 281 consecutive patients who underwent
a total/completion total thyroidectomy, 244 (86.8 %) did
not require any oral calcium and/or calcitriol supplements
(group 1), while 37 (13.2 %) did (group 2) at hospital
discharge. 25-OHD level was checked 1 day before sur-
gery, and postoperative quick parathyroid hormone (PTH)
was checked at skin closure (PTH-SC). Postoperative
serum calcium was checked regularly. Hypocalcemia was
defined by the presence of symptoms or adjusted calcium of
\1.90 mmol/L. Significant factors for hypocalcemia were
determined by univariate and multivariate analyses. The
accuracy of PTH-SC in predicting hypocalcemia was
measured by area under a receiver operating characteristic
curve (AUC), and the AUC of PTH-SC was compared
between patients with preoperative 25-OHD \15 and C15
ng/mL via bootstrapping.
Results. Preoperative 25-OHD level was not significantly
different between groups 1 and 2 (13.1 vs. 12.5 ng/mL,
p = 0.175). After adjusting for other significant factors,
PTH-SC (odds ratio 2.49, 95 % confidence interval
1.52–4.07, p \ 0.001) and parathyroid autotransplantation
(odds ratio 3.23, 95 % confidence interval 1.22–8.60,
p = 0.019) were the two independent factors for hypocal-
cemia. The AUC of PTH-SC was similar between those
with 25-OHD \15 and C15 ng/mL (0.880 vs. 0.850,
p = 0.61)
Conclusions. Low 25-OHD was not a significant factor for
hypocalcemia and did not lower the accuracy of quick PTH
in predicting postthyroidectomy hypocalcemia.
Postoperative hypoparathyroidism leading to hypocalce-
mia is the one of the most frequent morbidities after total
thyroidectomy with a reported incidence ranging 3–40 %.[1,2]
Because potentially life-threatening hypocalcemia does not
usually develop until 24–48 h after surgery, hypoparathy-
roidism is one of the major reasons for delaying hospital
discharge and dissuading surgeons from ambulatory thyroid
surgery.[3,4] To safely manage postoperative hypoparathyr-
oidism/hypocalcemia and potentially shorten hospital stay,
previous authors have suggested the use of single postoper-
ative quick parathyroid hormone (qPTH) testing for
predicting of postthyroidectomy hypocalcemia.[3–7] Benefits
of single qPTH over other strategies such as serial calcium
(Ca) monitoring or serial percentage drop in postoperative
parathyroid hormone (PTH) are the reduced need for multi-
ple blood taking and shortened hospital stay.[6] Similar
predictive accuracies have been reported when it is taken at
skin closure or up to several hours after surgery.[8,9] We
preferred the qPTH level taken at skin closure (PTH-SC)
because it is convenient and does not inflict additional dis-
comfort on patients.[6]
However, it remains unclear whether preoperative vita-
min D level [as measured by 25-hydroxyvitamin D (25-
OHD)] affects the accuracy of single qPTH in predicting
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postoperative hypocalcemia. The current literature suggests
that it may be because some studies have reported that
preoperative 25-OHD is a significant factor for postoper-
ative hypocalcemia.[10–12] A recent study also showed that
the accuracy [when measured by the area under a receiver
operating characteristic curve (AUC)] of qPTH in pre-
dicting hypocalcemia might be lower in patients with low
25-OHD compared to patients with normal 25-OHD.[13]
Therefore, we hypothesized that 25-OHD may be a sig-
nificant factor for hypocalcemia, and a low 25-OHD level
may affect the accuracy of qPTH in predicting postthy-
roidectomy hypocalcemia. However, because the evidence
remains scarce and somewhat inconsistent, our study aimed
to find out whether the 25-OHD level was a significant
factor for hypocalcemia and to compare the predictive
accuracy of qPTH between patients with different levels of
25-OHD.
METHODS AND PATIENTS
From March 2011 to April 2012, all consecutive patients
who underwent either a total or completion total thyroidec-
tomy were analyzed. All operations were performed by the
same surgical team. The present study protocol was
approved by the local institutional review board. The pre-
operative 25-OHD was checked 1 day before surgery,
whereas the PTH-SC level was taken at skin closure (i.e.,
approximately 5–10 min after excision of the thyroid gland)
while the patient was still anesthetized. Another qPTH level
was taken on the next morning (approximately 18–24 h after
operation) on postoperative day 1 (PTH-D1). Serum Ca and
phosphate were checked preoperatively, within an hour after
operation, on the next morning and every 8–10 h until Ca
stabilized. There were 299 consecutive patients who under-
went total or completion total thyroidectomy over this
period. Those with concomitant selective central and/or
lateral neck dissection (n = 10) and incomplete 25-OHD or
qPTH values (n = 8) were excluded. Therefore, there were
281 patients (93.9 %) eligible for analysis. Eighty-one
patients were previously included in another study, but
because the 25-OHD data were not reported, they were
included in the present study.[6]
Clinically significant hypocalcemia (hypocalcemia) was
defined either by the presence of hypocalcemic symptoms or
when the postoperative serum Ca dropped \1.90 mmol/L
(normal range 2.11–2.55 mmol/L). Those with hypocalce-
mia were provided 500–1,500 mg oral Ca tablets initially,
and additional calcitriol was considered, up to 0.50 lg twice
daily, if Ca tablets alone failed to maintain normocalcemia.
The person responsible for prescribing oral Ca with or
without calcitriol supplements was unaware of the 25-OHD,
PTH-SC, or PTH-D1 results. The primary end point of the
study was hypocalcemia needing Ca with or without calci-
triol supplements at hospital discharge. At hospital
discharge, 244 patients (86.8 %) did not require any oral Ca
with or without calcitriol (group 1), and 37 (13.2 %) did
(group 2). Potential factors for hypocalcemia were deter-
mined by comparing patient characteristics and perioper-
ative biochemical variables between groups 1 and 2.
Surgical techniques, postoperative care, and follow-up
protocol had been previously described.[2,14] Thyroidec-
tomy was performed in a standardized manner with the
patient under general anesthesia. The strap muscles were
separated in the midline and retracted laterally. Both
recurrent laryngeal nerves and parathyroid glands were
routinely identified and preserved. Any devascularized
parathyroid glands were immediately minced and autoim-
planted to the ipsilateral sternocleidomastoid muscle. All
postoperative patients were seen within 1 week and were
asked specifically about hypocalcemic symptoms after
hospital discharge. All data including patient biochemistry
and supplements at discharge were prospectively recorded.
Laboratory Methods
Serum albumin–adjusted Ca and phosphate levels were
measured in the hospital laboratory by standard methods
with the Modular Analytic system (Roche Diagnostics,
Indianapolis, IN). qPTH level was measured by Access 2
immunoassay system (Beckman Coulter, Brea, CA), and
the inter- and intra-assay coefficients of variation (CVs)
were 5.8 and 4.5 %, respectively. The normal range for
serum qPTH level was 1.2–5.7 pmol/L (to convert pmol/L
to ng/L, divide by 0.106). Serum 25-OHD was measured
with the electrochemiluminescence immunoassay (Elecsys
Vitamin D Total assay), and the inter- and intra-assay CVs
were 6.2 and 4.8 %, respectively. The measuring range was
3.00–70.0 ng/mL (to convert ng/mL to nmol/L, multiply by
2.496).
Statistical Analysis
For comparison of dichotomous variables between two
groups, chi-square tests and Fisher’s exact tests were used.
The Mann-Whitney U test was used for comparison of
continuous variables. Any preoperative and perioperative
biochemical variables that were significant in the univariate
analysis were entered into multivariate analysis to deter-
mine independent factors. To improve clinical utility of
significant continuous variables, Youden’s index was used
to calculate the best cutoff value for predicting hypocal-
cemia.[15] The AUC was used to measure the predictive
accuracy. AUC values closer to 1 meant better predict-
ability, whereas values closer to 0.5 meant poorer
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predictability. A bootstrap approach with 1,000 resamples
was used to estimate 95 % confidence intervals (CIs) for
AUC and to compare two AUCs. All statistical analyses
were conducted by SPSS software, version 18.0 (SPSS,
Chicago, IL), and R software, version 2.14.0 (R Foundation
for Statistical Computing, Vienna, Austria). p \ 0.05 was
considered statistically significant.
RESULTS
In this cohort, the median age was 53.2 (22.9–87.4) years,
and the male:female ratio was 1:7.3. Two hundred sixty-one
patients (92.9 %) underwent a total thyroidectomy, and 20
(7.1 %) underwent a completion total thyroidectomy. Of the
37 patients (13.2 %) requiring supplements at discharge
(group 2), 14 (5.0 %) required Ca tablets alone, and 23
(8.2 %) required both Ca and calcitriol supplements. At
follow-up, none experienced unexpected hypocalcemic
symptoms or required readmission. The median 25-OHD
level was 12.9 (3.0–33.1) ng/mL, with 83 patients (29.5 %)
having 25-OHD\10 ng/mL.
Table 1 lists patient baseline characteristics, operative
findings, and perioperative biochemistry between group 1
and group 2. Age at operation, sex ratio, surgical indica-
tions, preoperative thyroid-stimulating hormone level,
blood loss, weight of excised gland, and size of dominant
nodule were similar between the two groups. Group 2 had a
significantly higher incidence of concomitant thyroiditis
(27.0 vs. 11.5 %, p = 0.005) and longer duration of
operation (68 vs. 53 min, p = 0.002) than group 1. The
latter probably reflected the difficulty of the operation.
Group 2 also had significantly higher proportion of para-
thyroid gland autotransplantation (64.9 vs. 20.5 %, p =
0.019). Interestingly, both preoperative adjusted Ca and 25-
OHD levels were similar in the two groups. As expected,
both PTH-SC and PTH-D1 were significantly higher in
group 1 than group 2 (3.5 vs. 0.7 pmol/L, p \ 0.001 and
2.5 vs. 0.3 pmol/L, p \ 0.001, respectively). PTH-SC level
significantly correlated with PTH-D1 (q = 0.634, p \
0.001).
Table 2 shows a multivariable analysis of risk factors
for postoperative hypocalcemia. After adjusting for PTH-
D1 level, duration of operation and concomitant autoim-
mune thyroiditis, the PTH-SC level [b coefficient = 0.912,
odds ratio (OR) 2.488 (95 % CI 1.520–4.065), p \ 0.001]
and parathyroid autotransplantation (b coefficient = 1.173,
OR 3.231, 95 % CI 1.215–8.597, p = 0.019) were the two
independent factors for hypocalcemia. As PTH-SC signif-
icantly correlated with PTH-D1, the multivariate analysis
was repeated with PTH-D1 removed. However, PTH-SC
and parathyroid autotransplantation remained independent
factors for hypocalcemia.
Table 3 shows a comparison of test sensitivity, speci-
ficity, and predictability as measured by AUC between
preoperative 25-OHD, PTH-SC, PTH-D1, and PTH-SC
when 25-OHD\15 and C15 ng/mL. The best cutoff value
in predicting hypocalcemia for PTH-SC was 1.5 pmol/L
(Youden’s index 0.618, sensitivity 73.0 %, specificity
88.9 %) and for PTH-D1 was 0.9 pmol/L (Youden’s index
0.589, sensitivity 70.3 %, specificity 90.6 %). In terms of
overall predictability (as measured by AUC), PTH-SC had
a higher AUC value (0.866) than preoperative 25-OHD
(AUC = 0.570) and PTH-D1 (AUC = 0.818). Because
PTH-SC had the highest AUC, it was chosen for comparing
accuracy between those with 25-OHD \15 and C15 ng/
mL. The overall predictability (AUC) of PTH-SC was
similar between those with 25-OHD \15 and C15 ng/mL
(0.880 vs. 0.850, p = 0.61).
Figure 1 shows the AUC of PTH-SC in the group with
25-OHD\15 ng/mL and the group with 25-OHD C15 ng/
mL.
Table 4 shows the subgroup analysis of 25-OHD and
PTH-SC levels between groups 1 and 2 after surgery. In the
subgroup with PTH-SC \1.5 pmol/L, group 1 had signifi-
cantly higher median 25-OHD (17.2 vs. 12.6 ng/mL,
p = 0.025) and PTH-SC (1.2 vs. 0.6 pmol/L, p = 0.019)
levels than those in group 2. However, when both factors
were entered into multivariate analysis, PTH-SC (b coef-
ficient = 1.919, OR 6.803, 95 % CI 1.570–29.412, p =
0.010) was the only independent factor for hypocalcemia.
In the subgroup with PTH-SC C1.5 pmol/L, PTH-SC
tended to be higher in group 1 but did not reach signifi-
cance (p = 0.063). In group 2, the proportion requiring
both Ca and calcitriol supplements (instead of Ca tablets
only) was similar between PTH-SC\1.5 and C1.5 pmol/L
(17 of 27, 63.0 %, vs. 6 of 10, 60.0 %, p = 1.000).
DISCUSSION
Because 25-OHD level plays an essential role in both Ca
and PTH regulation, it has been hypothesized that perhaps
preoperative 25-OHD level could be a significant factor
affecting the risk of hypocalcemia and altering the accu-
racy of qPTH in predicting hypocalcemia after total
thyroidectomy.[16] Our study aimed at addressing these two
related issues by evaluating whether preoperative 25-OHD
was a significant factor in postthyroidectomy hypocalcemia
and examining whether preoperative 25-OHD level affec-
ted the accuracy of single qPTH in predicting
hypocalcemia. For the first issue, several studies found
preoperative 25-OHD could be a significant factor of
hypocalcemia.[10–12,17] Erbil et al. reported the results of
130 patients with nontoxic multinodular goiter undergoing
total thyroidectomy and found preoperative 25-OHD level
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to be an independent factor for postoperative hypocalcemia
(OR 558.5, 95 % CI 27.6–11, 291.9). They also reported
that 25-OHD was a more significant factor than 12 h PTH
and age for hypocalcemia.[10] A recent study similarly
reported that the preoperative 25-OHD level was a signif-
icant factor for hypocalcemia, with patients with 25-OHD
B14 ng/mL having significantly greater risk of hypocal-
cemia than 25-OHD [14 ng/mL.[12] This appeared
independent of the postoperative PTH level.[12] As a result,
some authors suggested routine Ca or vitamin D supple-
mentation for patients with preoperative 25-OHD \15 ng/
mL to avoid postoperative hypocalcemia.[11,18] However,
the association between low 25-OHD and hypocalcemia
has not been consistently demonstrated with some studies
showing no significant association.[3,19] Our study showed
that there was no significant association between 25-OHD
and hypocalcemia. When patient characteristics and
biochemistry were compared between groups 1 and 2,
TABLE 1 Comparison of baseline characteristics and perioperative biochemistry between those with normocalcemia (group 1) and with
hypocalcemia (group 2) after surgery
Variable Group 1 (n = 244) Group 2 (n = 37) p
Age at operation, years 54.0 (26.2–87.4) 48.3 (22.9–76.5) 0.246
Gender, M:F 32:212 2:35 0.278
Surgical indication/final pathology 0.323
Graves disease/toxic MNG 10 (4.2) 6 (16.2)
Benign pathology 210 (86.1) 29 (78.4)
Malignancy 24 (9.8) 2 (5.4)
Preoperative TSH level, mIU/L 1.0 (0.03–5.1) 0.96 (0.03–4.9) 0.342
Concomitant autoimmune thyroiditis 28 (11.5) 10 (27.0) 0.005
Duration of operation, min 53 (39–185) 68 (46–140) 0.002
Blood loss, mL 10 (5–110) 10 (10–60) 0.116
Weight of excised gland, g 33.7 (6–162) 39.0 (16–74) 0.251
Size of dominant nodule, cm 2.0 (0.4–6.5) 2.75 (0.5–3.5) 0.677
No. of parathyroid glands identified 0.107
0 14 (5.7) 0 (0.0)
1 14 (5.7) 1 (2.7)
2 59 (24.2) 11 (29.7)
3 61 (25.0) 15 (40.5)
4 96 (39.3) 11 (29.7)
Parathyroid autotransplantation 50 (20.5) 24 (64.9) \0.001
Preoperative adjusted calcium, mmol/L 2.28 (2.13–2.47) 2.29 (2.12–2.44) 0.981
Preoperative 25-OHD level, ng/mL 13.1 (3.1–33.1) 12.5 (3.0–23.9) 0.175
PTH-SC, pmol/L 3.5 (0.3–16.8) 0.7 (0.2–4.9) \0.001
PTH-D1, pmol/L 2.5 (0.3–11.0) 0.3 (0.3–6.1) \0.001
Bold values indicate p \ 0.05
MNG multinodular goiter, TSH thyroid-stimulating hormone, 25-OHD 25-hydroxyvitamin D, PTH-SC postoperative quick intact parathyroid
hormone at skin closure, PTH-D1 quick intact parathyroid hormone level on postoperative day 1
Data are presented as n (%) or median (range)
TABLE 2 Multivariable analysis of risk factors for postoperative
hypocalcemia requiring calcium and/or vitamin D supplementation
after surgery
Covariate b
coefficient
Odds ratio (95 %
confidence interval)
p
PTH-SC, pmol/L 0.912 2.488 (1.520–4.065) \0.001
PTH-D1, pmol/L 0.073 1.075 (0.687–1.684) 0.750
Duration of operation,
min
0.002 1.002 (0.985–1.019) 0.810
Concomitant
autoimmune
thyroiditis
1.179 3.252 (0.837–12.627) 0.144
Parathyroid
autotransplantation
1.173 3.231 (1.215–8.597) 0.019
Bold values indicate p \ 0.05
PTH-SC postoperative quick intact parathyroid hormone at skin clo-
sure, PTH-D1 quick intact parathyroid hormone level on
postoperative day 1
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25-OHD level was not significantly different (13.1 vs.
12.5 ng/mL, p = 0.175). Instead, the PTH-SC (OR 2.49)
and parathyroid autotransplantation (OR 3.23) were the
two most significant factors for hypocalcemia. Other
studies also found similar findings.[20,21] The reasons why
parathyroid autotransplantation might be significant are 2-
fold. First, there might have been a selection bias, with
patients perceived of having higher risk of hypocalcemia
more likely undergoing parathyroid autotransplantation.
Second, although parathyroid autotransplantation may
reduce permanent hypocalcemia in the long term, it tends
to increase temporary hypocalcemia.[22]
Given that we did not find a significant association
between 25-OHD and hypocalcemia, we proceeded with a
post hoc subgroup analysis (Table 4) looking at the two
different patient subgroups of PTH-SC, \1.5 and
C1.5 pmol/L. We postulated that perhaps patients with low
qPTH (i.e., PTH \ 1.5 pmol/L) might have been more sus-
ceptible to hypocalcemia when the 25-OHD was low than
when 25-OHD was normal. Although we did find group 2
TABLE 3 Comparison of test sensitivity, specificity, and predictability
Level Best cutoff valuea Sensitivityb Specificityc AUC (95 % CI)
Preoperative 25-OHD level, ng/mL \17, C17 33/37 (89.2 %) 80/244 (32.8 %) 0.570 (0.476–0.644)
PTH-SC, pmol/L \1.5, C1.5 27/37 (73.0 %) 217/244 (88.9 %) 0.866 (0.800–0.931)
PTH-D1, pmol/L \0.9, C0.9 26/37 (70.3 %) 221/244 (90.6 %) 0.818 (0.084–0.280)
PTH-SC, pmol/L, when 25-OHD \15 ng/mL \1.5, C1.5 17/23 (73.9 %) 133/144 (92.3 %) 0.880 (0.791–0.969)d
PTH-SC, pmol/L, when 25-OHD C15 ng/mL \1.5, C1.5 10/14 (71.4 %) 84/100 (84.0 %) 0.850 (0.771–0.929)d
AUC area under the receiver operating characteristic curve, CI confidence interval, 25-OHD 25-hydroxyvitamin D, PTH-SC postoperative quick
intact parathyroid hormone at skin closure, PTH-D1 quick intact parathyroid hormone level on postoperative day 1
a Determined by the ROC curve and Youden’s index[15]
b Test sensitivity = [truly positive/(truly positive ? falsely negative)]
c Test specificity = [truly negative/(truly negative ? falsely positive)]
d p value for the difference between the 2 AUCs was 0.61
FIG. 1 Areas under the receiver operating characteristic curve for
quick parathyroid hormone at skin closure in the group with
25-hydroxyvitamin D (25-OHD) \15 ng/mL (blue line) and the
group with 25-OHD C15 ng/mL (orange line)
TABLE 4 Subgroup comparison of 25-OHD and PTH-SC between those with normocalcemia (group 1) and with hypocalcemia (group 2) after
total thyroidectomy
Variable Group 1 (n = 244) Group 2 (n = 37) Univariate p value Multivariate p valuea
PTH-SC \1.5 pmol/L (n = 54)
25-OHD level, g/mL 17.2 (7.3–31.4) 12.6 (3.5–24.0) 0.025 0.081
PTH-SC level, pmol/L 1.2 (0.3–1.4) 0.6 (0.2–1.4) 0.019 0.010
PTH-SC C1.5 pmol/L (n = 227)
25-OHD level, g/mL 12.7 (3.1–33.1) 12.3 (3.0–18.3) 0.215 –
PTH-SC level, pmol/L 3.9 (1.6–16.8) 2.9 (1.9–4.9) 0.063 –
Bold values indicate p \ 0.05
25-OHD 25-hydroxyvitamin D, PTH-SC postoperative quick intact parathyroid hormone at skin closure
a Multivariate analysis was performed when both factors (25-OHD and PTH-SC) were significant (p \ 0.05) in the univariate analysis
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had significantly lower 25-OHD level than group 1, when
both 25-OHD and PTH-SC were entered into a multivariate
analysis, only PTH-SC was a statistically significant factor
for hypocalcemia. Therefore, a low 25-OHD may only have a
minor or weak effect on hypocalcemia even when PTH-SC is
\1.5 pmol/L, and conversely, a normal 25-OHD level may
not be able to compensate for the low qPTH level in pre-
venting hypocalcemia. It was also interesting that when only
group 2 patients were considered, the proportion needing
both Ca with calcitriol supplementation was similar between
PTH-SC \1.5 and C1.5 pmol/L (63.0 vs. 60.0 %,
p = 1.000). This was despite the fact that the former group
had significantly lower PTH-SC level than the latter group
(0.6 vs. 2.9 pmol/L, p \ 0.001). One explanation for this
discrepancy may be that despite a detectable PTH by the
assay, the amount of PTH available in the serum to maintain
normocalcemia remained low.[23] Furthermore, there might
have been other factors, including parathyroid autotrans-
plantation, that could influence the risk of hypocalcemia; in
addition, PTH-SC was not a test with 100 % accuracy.
In our second analysis, we aimed to find out whether low
preoperative 25-OHD level affected the accuracy of single
qPTH in predicting hypocalcemia by comparing the AUC of
PTH-SC when 25-OHD\15 ng/mL with the AUC of PTH-
SC when 25-OHD C15 ng/mL. However, unlike a previous
study reporting that the AUC of qPTH was lower in 25-OHD
\10 ng/mL than in C10 ng/mL (0.68 vs. 0.93), we found
that the two groups had similar accuracy by AUC (0.88 vs.
0.85, p = 0.61).[13] This was despite our study having a
significant larger cohort. In other words, PTH-SC had similar
accuracy in predicting postthyroidectomy hypocalcemia
regardless of whether the preoperative 25-OHD was\15 or
C15 ng/mL. However, because the number of studies
focusing on this issue is small, our finding requires further
confirmation by future prospective studies.
Our data support the view that routine testing of serum
25-OHD level before total thyroidectomy is unnecessary
because it neither predicts nor affects the risk of hypocalce-
mia. Regarding whether routine preoperative vitamin D
supplementation would be beneficial in patients who undergo
total thyroidectomy, this was not addressed and will require
further evaluation. One of the shortcomings of our study was
that because a sample calculation was not performed, our
findings might have been purely the result of the underpow-
ering of the study. However, this study was one of the largest
studies of its kind with all data collected prospectively.
In conclusion, PTH-SC and parathyroid autotransplan-
tation were the two independent factors or predictors for
hypocalcemia after thyroidectomy, whereas preoperative
25-OHD level was not. Preoperative 25-OHD level was
also not a significant factor for hypocalcemia in patients
with PTH-SC \1.5 pmol/L. The accuracy of PTH-SC in
predicting hypocalcemia appeared similar between patients
with preoperative 25-OHD \15 and C15 ng/mL.
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